Pre-Bid now on over 2000 items...our LIVE Auction is happening November 2nd

Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories


More Industry Headlines

Researchers use MR to guide stem cell therapy for neurological disorders Provides the resolution that's needed

Alternative Mo-99 SPECT isotope in development Production on alternative metals could stabilize supply

With MR, researchers say they have found the root cause of depression Could lead to more effective treatments

Abbott in $1.2 billion deal to sell device businesses to Terumo Transaction depends on the completion of Abbott's St. Jude acquisition

Philips partners with FluoroPharma to enhance CardioPET tracer image quality Study data presented at EANM annual congress

With MR, new biomarker helps researchers monitor brain cancer progress How MR spectroscopy and 2HG are shedding new light on brain tumors

Harley Street site for proton facility faces protest from local London residents Dame Barbara Windsor leads the opposition

Researchers use imaging to investigate the link between ACL surgery and osteoarthritis Can they find a treatment?

Proposed CMS hospital outpatient department rule detrimental for imaging services in CY 2017 Hospitals must communicate with CMS

IBM and Quest launch personalized big-data cancer care program Cognitive computing meets genomic sequencing

IBA spin-off, Novation ink PET radiopharmaceutical deal

by Brendon Nafziger , DOTmed News Associate Editor
Ion Beam Applications S.A.'s newly spun-off radiopharmaceutical wing IBA Molecular has inked a five-year deal with group purchasing organization Novation LLC to supply its member health care facilities with PET radiotracers.

Under the deal, announced Monday, IBA Molecular will supply imaging agents, including 18-Fluorodeoxyglucose, as well as provide educational and training services. The contract took effect July 1. Terms of the deal weren't disclosed.

Story Continues Below Advertisement

Streamline Your Radiology Workflow with RamSoft's PowerServer RIS/PACS

The PowerServer RIS/PACS is a single database application, essential to reducing redundant work, limiting manual data entry, and increasing consistency throughout healthcare practices. Click to learn how it will help you improve patient care and more.

IBA Molecular has 54 PET isotope facilities in Europe, North America and Asia. It also delivers agents for SPECT imaging worldwide.

SK Capital Partners holds a controlling stake in IBA Molecular, which was spun off from its Belgian parent company, which retains a minority stake, in April.


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.